Paramount Skydance settles antitrust dispute with states over Warner Bros. Discovery deal

Paramount-Skydance settled a state antitrust lawsuit over its $110B Warner Bros Discovery merger. The deal mandates 30-32 annual film releases, $1.5B in US production spending, and operational restrictions. Non-compliance risks penalties. The Writers Guild also settled, securing $17.5M for its health fund. According to Paramount, these resolutions clear the final regulatory hurdles for the merger.

Paramount CEO David Ellison agreed to invest $1.5B in U.S. production over five years, resolving a legal dispute with California and allowing its $81B merger with Warner Bros. Discovery. The deal ensures Paramount remains based in Los Angeles and avoids $650M quarterly fees for missing the 1 October deadline. According to the Wall Street Journal, the agreement includes penalties for unmet commitments and guarantees editorial independence for CBS and CNN.

AMD, WBD, and MRNA stocks reached 52-week highs. AMD surged 10% to a $1T market cap, driven by AI optimism. WBD rose 11% as its $110B merger with Paramount nears completion. MRNA climbed 12% on positive Phase 3 trial data presentation plans. Retail sentiment improved for all three stocks.

Paramount has reached an agreement with 12 state attorneys general regarding its $110 billion acquisition of Warner Bros. Discovery, clearing a regulatory hurdle.

Paramount Skydance settled lawsuits with US states and the Writers Guild of America, clearing a major legal hurdle for its $110 billion acquisition of Warner Bros Discovery. The deal requires Paramount to increase film production and meet certain content commitments. Warner Bros Discovery shares rose over 10% on the news.

Paramount Skydance settled a legal battle over its $110B acquisition of Warner Bros Discovery, agreeing to film quotas and a news oversight committee. The deal, which faces criticism, will create one of the largest media mergers in history. Shares of Warner Bros Discovery surged over 10%.